Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.
about
Adverse drug reactions.Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practiceRecognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinantsContribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.The spontaneous reporting of adverse drug reactions by nurses.Assessment of therapeutic safety in systematic reviews: literature review.Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.Adverse drug reactions: back to the futureAdvances in targeted therapy: safety of biological agentsPharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting processJoining the DoTS: new approach to classifying adverse drug reactionsExploring Spanish health social media for detecting drug effects.Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists' interventional study.New active substances authorized in the United Kingdom between 1972 and 1994.The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination schemeObstacles and solutions for spontaneous reporting of adverse drug reactions in the hospitalReported paediatric adverse drug reactions in the UK 2000-2009Spontaneous reporting--of what? Clinical concerns about drugs.Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.Accuracy of hepatic adverse drug reaction reporting in one English health region.Pharmacovigilance in developing countries.A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.Collecting and sharing information about harms.Newly licensed drugs.A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests
P2860
Q24524192-975EA045-BA5F-4E80-BEF3-1DF0F68465B0Q24644040-20FE63EB-EB58-46A5-9C32-D408CCFD3A2FQ28651397-DDA943A2-9CB6-4BE9-8F2B-F5C82AC2357BQ33815256-6DF9B7C1-E43E-4209-BD55-7D71662B0CD8Q34347629-CD8F961C-2529-465D-AB4A-934C58DEE871Q34362114-E9A088E8-04DF-4BE5-89AF-C11D1C3DDEACQ35120643-C22F3EE1-E577-4138-B006-2345E5E75CBCQ35130832-3427F657-8045-4B08-BC49-735FF0689415Q35553474-CE7016FC-B7C1-4A8B-8606-7CF6AFD83A30Q35573314-40514639-CB48-4C18-8F4E-D72B1B58301AQ35590133-B6D6D7DC-EF82-449C-B8D6-EB35DAC2C36AQ35671300-FA3BC2F4-FE98-47EC-ABCE-C45FDEE2D8A1Q35753884-6A95B5F2-3B97-4668-902D-21D94DB63710Q35802118-1FF60FF8-0F6C-4913-8330-6EB8A140DF33Q35825558-2E2A8BA4-71F4-4FC8-B468-BC6029229475Q35827061-8CA8B9C6-F4FF-4B0D-8718-B9779056FC1FQ36017395-85C5FF6A-FE2D-442F-BE3C-859665FCF522Q36053599-4DC47523-391E-4806-911F-7DAB8FFDA67BQ36053990-F7709012-40C6-442D-9E25-F846A4FEB141Q38640960-655D727F-6265-42DD-8EF0-6A5E0400EF30Q42384808-0CDA4963-131F-4F18-BA10-352E62938335Q42758716-D3B60594-DEE0-4CEA-A27F-E31132C2D1A6Q43023261-12E23F0C-CF1B-471B-88CF-808BA85D96F4Q43112947-C56EC9DD-65C4-4AFF-975C-6F9884B1700EQ59136746-9C869CDF-8658-4650-BB96-B6EAD2C5ECB2
P2860
Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@en
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@nl
type
label
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@en
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@nl
prefLabel
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@en
Pharmacovigilance: paradise lo ...... illiam Withering Lecture 1994.
@nl
P1476
Pharmacovigilance: paradise lo ...... William Withering Lecture 1994
@en
P2093
M D Rawlins
P577
1995-01-01T00:00:00Z